{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:15:03Z","timestamp":1774948503452,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":5189,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1994,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>OBJECTIVE <\/jats:bold> Graves' disease is associated with different HLA genes in Caucasians and the Chinese, in whom the HLA associations may be stronger in males than females. Common HLA\u2010associated susceptibility in both races may occur at the HLA\u2010DQ loci. The aims of this study were to examine the HLA\u2010A, B, DR and DQ associations with Graves' disease in a Hong Kong Chinese population and to determine whether the HLA associations differ between the sexes and between subjects with and without thyrotoxic periodic paralysis.<\/jats:p><jats:p><jats:bold>DESIGN <\/jats:bold> HLA\u2010A, B and DR types were determined by serological typing and DQA1 and DQB1 alleles by oligonucleotide probing of the respective enzymatically amplified gene.<\/jats:p><jats:p><jats:bold>PATIENTS <\/jats:bold> Ninety\u2010seven Chinese patients with Graves' disease (31 males with, 35 males without and 31 females without thyrotoxic periodic paralysis) and 105 racially matched healthy controls.<\/jats:p><jats:p><jats:bold>MEASUREMENTS <\/jats:bold> Frequencies of HLA types\/alleles at each locus were compared between patients and controls and between the Graves' subgroups using the \u03c7<jats:sup>2<\/jats:sup> test.<\/jats:p><jats:p><jats:bold>RESULTS <\/jats:bold> HLA\u2010B46, DR9 and DQB1*0303 were associated with Graves' disease in males only; these associations were weaker in males with thyrotoxic periodic paralysis. DR12, DQA1*0401 and DQB1*0301 were protective, regardless of sex or the presence of thyrotoxic periodic paralysis. The positive HLA associations in the Hong Kong Chinese were distinct from those in Caucasians whereas the protective haplotype was similar to that described in Caucasians.<\/jats:p><jats:p><jats:bold>CONCLUSIONS <\/jats:bold> These findings call in question the role of HLA genes in disease susceptibility but suggest a role for HLA in protection from Graves' disease.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1994.tb02444.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T11:02:12Z","timestamp":1205751732000},"page":"63-66","source":"Crossref","is-referenced-by-count":44,"title":["The HLA association with Graves' disease is sex\u2010specific in Hong Kong Chinese subjects"],"prefix":"10.1111","volume":"40","author":[{"given":"D. A.","family":"Cavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Penny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. H.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mijovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. S.","family":"Cockram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. R.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-4-863"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00399959"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb03421.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1985.tb00220.x"},{"key":"e_1_2_1_6_1","first-page":"75","article-title":"Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existance of four subpopulations","volume":"38","author":"Inoue D.","year":"1985","journal-title":"Clinical Endocrinology"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00404086"},{"key":"e_1_2_1_8_1","first-page":"106","volume-title":"Detection of Immune\u2010Associated Genetic Markers of Human Disease","author":"Mathews J.D.","year":"1984"},{"key":"e_1_2_1_9_1","first-page":"541","article-title":"Relative predispositional effects (RPEs) of marker alleles with disease: HLA\u2010DR alleles and Graves' disease","volume":"45","author":"Payami H.","year":"1989","journal-title":"American Journal of Human Genetics"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.3.496"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-5-1075"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb00461.x"},{"key":"e_1_2_1_13_1","first-page":"336","article-title":"Association of HLA\u2010DR tissue types with Graves' disease in Taiwan","volume":"88","author":"Tsai K.S.","year":"1989","journal-title":"Journal of the Formosan Medical Association"},{"key":"e_1_2_1_14_1","first-page":"619","article-title":"Immunogenetics of Graves' ophthalmopathy","volume":"28","author":"Weetman A.P.","year":"1988","journal-title":"Clinical Endocrinology"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb00466.x"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6142.930"},{"key":"e_1_2_1_17_1","first-page":"1341","volume-title":"Progress in Endocrinology","author":"Yeo P.P.B.","year":"1988"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1989.tb01734.x"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1994.tb02444.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1994.tb02444.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T08:21:19Z","timestamp":1698222079000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1994.tb02444.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["10.1111\/j.1365-2265.1994.tb02444.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02444.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}